Secure a robust merchant account for your supplement business.

For supplement and nutra merchants, the most common failure point is the abrupt closure of a functioning merchant account. One day, sales are flowing; the next, you are locked out. Mainstream processors like Stripe, Wise, or Airwallex often use automated systems that flag accounts based on industry codes, transaction patterns, or a sudden spike in chargebacks. Once flagged, a manual review, if it happens at all, is often cursory and defaults to termination to eliminate perceived risk.

Another frequent problem is outright rejection during onboarding. You submit your application, provide all the requested documentation, and are met with a generic denial. The reason is simple: your business type is on their prohibited list. These lists are rarely public, so you only discover the issue after wasting time and effort. This is particularly true for businesses selling products with complex ingredient lists, making specific health claims, or operating a subscription model, all of which are red flags for standard acquirers. The result is a cycle of applications and rejections that can stall a business before it even scales.

The 'high-risk' label applied to supplement companies is not arbitrary. It stems from a combination of commercial and regulatory pressures on acquiring banks and payment processors. Firstly, the industry has historically higher chargeback rates. Dissatisfied customers or subscription billing issues can lead to disputes, and processors have low tolerance for chargeback ratios exceeding 0.9%. Secondly, regulatory bodies like the FDA in the US or EFSA in Europe impose strict rules on product claims, ingredients, and marketing. Acquirers fear being indirectly associated with non-compliant businesses, which could lead to fines and loss of their own banking relationships.

Product liability is another significant factor. If a customer has an adverse reaction to a supplement, the legal and financial fallout can be substantial. Mainstream banks are not structured to assess this kind of product-specific risk. They see only potential liability and reputational damage. Finally, the use of aggressive marketing tactics and complex recurring billing models by some players in the nutra space has damaged the industry's reputation. As a result, underwriters at conservative institutions prefer to decline the entire category rather than invest in the granular due diligence required to separate good actors from bad.

When mainstream options are off the table, you must look to specialist acquirers. These are not the household names you see advertised on billboards. They are specific types of institutions in jurisdictions that have built regulatory frameworks to support higher-risk industries. For supplement companies, this often means turning to acquiring banks in the European Union and the United Kingdom that are purpose-built for global e-commerce and have explicit policies for nutra businesses. These institutions have sophisticated compliance teams capable of reviewing product labels, ingredient lists, and marketing copy to ensure everything is in order.

Beyond Europe, certain payment institutions in offshore jurisdictions can also be viable. These are not shadowy, unregulated entities; they are licensed financial institutions that simply have a higher risk appetite. They compensate for this risk with more intensive onboarding and monitoring. For larger, more established businesses, we might explore options with specific US-based acquiring banks that partner with Independent Sales Organisations (ISOs) specialising in high-risk verticals. These setups are more complex and expensive but provide access to domestic payment rails. The key is to engage with acquirers that actively want your business type, rather than trying to fit a square peg into a round hole with a fintech that primarily serves SaaS companies.

Our process is not about submitting dozens of applications. It is a targeted, methodical approach. First, we conduct a deep dive into your business. This involves a comprehensive assessment of your corporate structure, directors' history, product labels, supplier agreements, marketing materials, and historical processing statements. We need to see everything an underwriter would see, warts and all. This allows us to identify any potential red flags upfront and build a coherent narrative around your business. We are looking for compliant, well-run companies that have simply been miscategorised by risk-averse providers.

Once we have a complete picture, we prepare a detailed submission package. This is not just a collection of documents; it is a professional presentation that anticipates and addresses the acquirer's questions. We then leverage our relationships to make a warm introduction to the right people at a suitable institution. We select the institution based on our knowledge of their specific risk appetite, industry preferences, and onboarding backlogs. We don't shop your profile around. We select the one or two best-fit partners and engage them directly, advocating on your behalf throughout the underwriting process. This curated approach significantly increases the probability of a successful outcome.

Ultimately, a handful of concrete factors determine approval. The most critical is your chargeback history. If you have existing or past processing statements, they must show a chargeback ratio consistently below 1%. If your ratio is higher, you need a credible plan to reduce it. Second is the clarity and compliance of your product labels and marketing. Health claims must be substantiated and compliant with the regulations in your target markets. Vague or overly aggressive claims are a major red flag. Third, the underwriters will scrutinise the business principals. They are looking for experienced founders with a clean history. Any past business failures or legal issues must be disclosed and explained proactively.

Your corporate structure and physical location also matter. A clear, transparent ownership structure is essential. Complex, multi-jurisdictional structures without a clear commercial rationale can be a deal-breaker. Finally, the bank needs to be confident in your business model's viability. You should have clear financial projections and demonstrate a professional understanding of your market. The underwriter's goal is to build a complete risk profile; the more organised, transparent, and compliant you are, the more likely they are to view you as a long-term partner rather than a short-term risk.

Securing a stable, long-term merchant account for a supplement business is neither fast nor cheap. Anyone promising instant approvals for a few hundred pounds is not credible. Realistically, you should budget for a timeline of 4 to 8 weeks from our initial engagement to a live merchant account. The first one to two weeks are spent on our internal due diligence and preparing your submission package. The following two to six weeks are in the hands of the acquiring bank's underwriting and compliance departments. This can vary depending on the complexity of your file and the institution's current workload.

In terms of cost, you should anticipate a placement or engagement fee for our services, which covers the intensive advisory and administrative work involved. This is separate from the fees charged by the acquiring bank itself. The acquirer may charge its own setup fee, typically ranging from zero to several thousand pounds, depending on the institution. Transaction rates will also be higher than those offered by Stripe or other low-risk processors. Expect to pay a percentage discount rate plus a per-transaction fee. While the upfront and ongoing costs are higher, this is the price of stability and access to the global payments system for a high-risk business.